William W Busse Selected Research

Omalizumab (Xolair)

1/2021	Possible Protective Effect of Omalizumab on Lung Function Decline in Patients Experiencing Asthma Exacerbations.
1/2021	What is the contribution of IgE to nasal polyposis?
10/2020	Aeroallergen Sensitization, Serum IgE, and Eosinophilia as Predictors of Response to Omalizumab Therapy During the Fall Season Among Children with Persistent Asthma.
1/2020	Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
1/2020	Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma.
1/2018	Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab.
12/2017	Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.
10/2017	Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.
10/2017	Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index.
9/2017	New and Anticipated Therapies for Severe Asthma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William W Busse Research Topics

Disease

190	Asthma (Bronchial Asthma) 11/2022 - 04/2002
45	Inflammation (Inflammations) 01/2022 - 04/2002
11	Hypersensitivity (Allergy) 01/2021 - 03/2003
9	Infections 01/2022 - 05/2002
8	Eosinophilia 10/2020 - 04/2003
7	Allergic Rhinitis 01/2021 - 01/2003
7	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 08/2011
6	Rhinitis 10/2019 - 01/2003
5	Airway Obstruction (Choking) 12/2021 - 01/2003
5	Virus Diseases (Viral Diseases) 01/2021 - 11/2002
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 10/2003
3	Pneumonia (Pneumonitis) 01/2019 - 08/2011
3	Anaphylaxis (Anaphylactic Shock) 03/2017 - 01/2006
3	Obesity 10/2016 - 06/2011
3	Nasopharyngitis 01/2016 - 06/2010
3	Respiratory Hypersensitivity 08/2009 - 12/2002
2	Nasal Polyps (Nasal Polyp) 01/2021 - 05/2014
2	Rhinosinusitis 01/2020 - 09/2002
2	Human Influenza (Influenza) 01/2018 - 06/2003
2	Bronchial Spasm 04/2016 - 11/2009
2	Respiratory Sounds (Crackle) 09/2014 - 05/2009
2	Oral Candidiasis (Thrush) 11/2012 - 01/2012
2	Overweight 02/2010 - 01/2010
2	Lung Diseases (Lung Disease) 05/2009 - 10/2005
2	Seasonal Allergic Rhinitis (Hay Fever) 01/2006 - 01/2006
1	Rheumatoid Arthritis 03/2022
1	Chronic Urticaria 01/2021
1	Perennial Allergic Rhinitis 11/2020

Drug/Important Bio-Agent (IBA)

55	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 09/2002
29	AllergensIBA 01/2022 - 01/2003
24	Immunoglobulin E (IgE)IBA 03/2022 - 03/2003
24	Biomarkers (Surrogate Marker)IBA 03/2022 - 09/2008
18	Omalizumab (Xolair)FDA Link 01/2021 - 09/2004
16	Biological ProductsIBA 01/2021 - 10/2005
15	fluticasone furoate FDA Link 11/2022 - 10/2011
14	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 02/2007
14	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 02/2007
14	CytokinesIBA 01/2021 - 11/2002
12	Monoclonal AntibodiesIBA 01/2020 - 09/2004
11	Interleukin-13IBA 01/2021 - 10/2012
11	AntigensIBA 12/2018 - 04/2002
10	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2003
10	anti-IgE antibodiesIBA 10/2020 - 10/2007
10	Fluticasone (Cutivate)FDA LinkGeneric 01/2019 - 10/2004
10	Budesonide (Pulmicort)FDA LinkGeneric 01/2017 - 03/2003
9	vilanterolIBA 11/2022 - 01/2012
9	SteroidsIBA 01/2021 - 05/2006
9	Interleukin-5 (Interleukin 5)IBA 01/2021 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 03/2016 - 09/2004
8	benralizumabIBA 01/2021 - 06/2010
7	Interleukin-4 (Interleukin 4)IBA 11/2020 - 09/2004
6	dupilumabIBA 01/2022 - 01/2018
6	InterleukinsIBA 01/2021 - 06/2003
6	Albuterol (Salbutamol)FDA LinkGeneric 04/2016 - 03/2003
5	Methacholine Chloride (Methacholine)FDA Link 10/2018 - 09/2004
5	Salmeterol Xinafoate (Serevent)FDA Link 06/2014 - 10/2004
4	RNA (Ribonucleic Acid)IBA 12/2021 - 10/2013
4	GlucocorticoidsIBA 10/2021 - 01/2011
4	ChemokinesIBA 05/2004 - 11/2002
3	Immunoglobulin G (IgG)IBA 10/2019 - 09/2003
3	Tiotropium Bromide (Spiriva)FDA Link 10/2018 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2018 - 11/2006
3	Messenger RNA (mRNA)IBA 11/2016 - 10/2013
3	Cholinergic Antagonists (Anticholinergics)IBA 04/2016 - 01/2016
3	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 10/2013 - 06/2008
3	Interleukin-33IBA 08/2013 - 07/2011
3	montelukast (Singulair)FDA Link 02/2010 - 01/2006
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 12/2005 - 09/2002
2	GSK573719IBA 11/2022 - 03/2016
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2019 - 11/2014
2	Chemokine ReceptorsIBA 09/2017 - 09/2003
2	SmokeIBA 10/2016 - 05/2011
2	Indicators and Reagents (Reagents)IBA 12/2015 - 09/2008
2	Formoterol Fumarate (Oxis)FDA Link 10/2013 - 06/2008
2	Platelet Factor 4IBA 07/2013 - 03/2012
2	P-SelectinIBA 07/2013 - 03/2012
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2012 - 01/2012
2	Superoxide DismutaseIBA 05/2011 - 08/2005
2	Oxidants (Oxidizing Agents)IBA 05/2011 - 08/2005
2	VaccinesIBA 04/2011 - 01/2011
2	IntegrinsIBA 06/2008 - 06/2006
2	Eosinophil-Derived NeurotoxinIBA 09/2004 - 04/2003
2	Chemokine CCL5IBA 06/2003 - 05/2002
1	16S Ribosomal RNAIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	MucinsIBA 12/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	allergen Bla g 1IBA 01/2021
1	InterferonsIBA 01/2021
1	AndrogensIBA 01/2020
1	Dehydroepiandrosterone SulfateIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020

Therapy/Procedure

59	Therapeutics 11/2022 - 09/2002
6	Dry Powder Inhalers 11/2012 - 08/2005
4	Immunotherapy 10/2021 - 01/2006
4	Biological Therapy 01/2021 - 03/2017
2	Nebulizers and Vaporizers (Inhaler) 11/2022 - 03/2016
2	Emergency Treatment 01/2017 - 01/2009
2	Metered Dose Inhalers (Metered Dose Inhaler) 04/2016 - 06/2008
1	Precision Medicine 01/2020